Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
An open-label, randomized phase I treatment trial (Parallel Assignment) to evaluate the impact of PRIM-DJ2727 (frozen vs capsules) in patients with active Ulcerative Colitis (UC) defined on clinical grounds (Partial Mayo score ≥ 3 with each subscore >1).
Disease severity as assessed by the Partial Mayo Score (PMS) for Ulcerative Colitis (UC), Change in fecal microbiota diversity and genera as assessed by sequencing, Change in proportion of antibody-coated microbiota as assessed by the antibiotic susceptibility test, Safety
No published results were found as of May 2026
…